Understanding patterns of evolution to develop high-performance enzymes
for a range of biological and industrial applications.
Entropix is an early-stage enzyme engineering company specialising in the directed evolution of high-performance enzymes and biocatalysts. Our protein engineering platform combines state-of-the-art experimental molecular technology and computational methods.
Our mission is to use directed evolution to develop novel enzymes that solve perennial challenges in diagnostic, life science, manufacturing, pharmaceutical, and food ingredient sectors.
We believe the directed evolution of enzymes will play a major role in delivering a truly sustainable economy: Entropix is part of this revolution.
We combine protein engineering, computational gene sequence analysis, enzyme structure analysis, and machine learning to direct the natural process of evolution.
The Entropix scientific team, led by Professor David Hornby, employs algorithmic computation to identify uncharted connections between amino acid sequences and enzyme function.
In addition to our enzyme developments, we have created a new technology (NADA™ and ALGO™) for the capture, recovery and purification of nucleic acids with numerous applications in diagnostics, forensics, recombinant protein production and molecular biology research.
Entropix has created an exciting new technology (called NADA™) for the capture, recovery and purification of nucleic acids. NADA™ is rapid, efficient and solvent-free and
https://www.youtube.com/watch?v=kvx4_jZ4-_g “We have had a positive and successful collaboration with the VEC over the last two years. Their skills and expertise in machine learning and
Entropix has recently received a six-figure investment from LYVA Labs’ Health and Life Sciences Fund to support the commercialisation of its enzyme technology and to